The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) and the Swiss Chemical Society, Division for Medicinal Chemistry & Chemical Biology (DMCCB) will be organising the International Symposium on Chemical Biology (EFMC-ISCB) on November 16-18, 2023 in Basel, Switzerland.
The Tübingen Center for Academic Drug Discovery (TüCAD2), founded 2012, is part of the University’s excellence strategy. TüCAD2 is closely connected to the Excellence Cluster iFIT, ICEPHA (Interfaculty Center for Pharmacogenomics) and recently to NCT-SW (Nationales Zentrum für Tumorerkrankungen-SüdWest) and focus on pharmacological validation of genetically identified targets. The strong translational focus brought four compounds until now “first into human”.
As a graduate/postgraduate teaching aspect, TüCAD2 organizes since 2019 a curriculum covering advanced medchem, preclinical development and fundraising aspects. As a new format, we will start now with a one-day event with case studies, presented by eminent drug discovery experts from both industry and academia.
- Medicinal chemistry case studies from leading drug discovery experts
(ANOVA, Bayer, Boehringer Ingelheim, Nuvisan, Sanofi, SpiroChem, Symeres, UCLA, Univ. Tübingen)
The EFMC | ACSMEDI Medicinal Chemistry Frontiers is co-organised as a collaboration between the EFMC (European Federation for Medicinal chemistry and Chemical biology) and the ACS (American Chemical Society) MEDI (Division of Medicinal Chemistry).
The program will include:
- 3 high quality plenary lectures.
- 9 sessions on key topics in Medicinal Chemistry.
- About 18 oral communications selected from the submitted abstracts
- An extensive social program to maximise your networking opportunities.
- A poster session and an exhibition.
The EFMC | ACSMEDI Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.